Navigation Links
Lorus Therapeutics Announces Exclusive Multinational License Agreement with Zoticon Bioventures for Virulizin(R)
Date:4/8/2008

arketing Authorization Application with the European Medical Evaluation Agency (EMEA). A drug that receives fast track designation must demonstrate that it is intended for the treatment of a serious or life-threatening condition and that it has the potential to address unmet medical needs for the condition.
Virulizin(R) is a registered trademark owned by Lorus Therapeutics Inc.

About Lorus

----------- Lorus is a biopharmaceutical company focused on the research and development of novel therapeutics in cancer. Lorus' goal is to capitalize on its research, preclinical, clinical and regulatory expertise by developing new drug candidates that can be used, either alone, or in combination with other drugs, to successfully manage cancer. Through its own discovery efforts and an acquisition and in-licensing program, Lorus is building a portfolio of promising anticancer drugs. Lorus Therapeutics Inc. is listed on the Toronto Stock Exchange under the symbol LOR, and on the American Stock Exchange under the symbol LRP.

About Zoticon

-------------

Zoticon is a privately held global drug development and healthcare investment firm with a portfolio of life-sciences-focused companies. Zoticon's business model is to in-license novel therapeutics, and the formation of new biotechnology companies.

For further information on Zoticon, please visit their website at http://www.zoticon.com.

Forward-Looking Statements for Lorus

------------------------------------

This press release contains forward-looking statements within the meaning of Canadian and U.S. securities laws. Such statements include, but are not limited to, statements relating to: financings and corporate reorganizations, the establishment of corporate alliances, the Company's plans, objectives, expectations and intentions and other statements including words such as "continue", "expect", "intend", "w
'/>"/>

SOURCE Lorus Therapeutics Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Lorus Advances Clinical Development of GTI-2040 Combined with Ara-C in Acute Myeloid Leukemia
2. Lorus Therapeutics Appoints Peter Korth as Chief Financial Officer
3. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
4. DJO Incorporateds Pending Merger With ReAble Therapeutics Clears U.S. Antitrust Review
5. PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation
6. Systems Medicine (SM), a Subsidiary of Cell Therapeutics, Inc. (CTI), Announces Execution of CRADA with NCI/NIH to Develop Potential Cancer Treatments Targeting the Insulin Growth Factor (IGF) Pathway
7. Amsterdam Molecular Therapeutics to Release H1 2007 Results on August 29, 2007
8. Nektar Therapeutics Appoints Tim Harkness as Chief Financial Officer
9. ExonHit Therapeutics: Allergan and ExonHits First Collaboration Compound to Begin Human Clinical Trials
10. Cell Therapeutics, Inc. Takes Corrective Actions in Response to Nasdaq Determination
11. Amsterdam Molecular Therapeutics Reports Half Year Results 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/9/2008)...HILL, N.C., Oct. 9 /- Pairing traditi...tworking and multi-channel marketing,are helping o...ons and stay,afloat financially in today,s market....s in Recessions, the 10th annual quality excellenc...L BENCHMARKING COUNCIL,executives from leading co...
(Date:10/9/2008)...umber 7 out of top 20 Employers Across Life Scienc...e/ -- EMD Serono, Inc., an affiliate,of Merck KGaA...been named,by Science magazine as a top employer i... ranking number 7 out of the top 20 employers,acro...cientific community has recognized EMD Serono,as a...
(Date:10/9/2008)...PTON, Pa., Oct. 9 /- Enviro...C" or the "Company") BioMedical,Division today ann...) XD,Monoplace Hyperbaric Chambers to Comprehensiv...hcare Solutions, a growing company who focuses,sol...itutes throughout the,United States, has purchased...
(Date:10/9/2008)...s to be used to support the achievement of several...stones of Acasti Pharma, LAVAL, QC, Oct. 9 /PRNew...ne Technologies & Bioressources Inc. ("Neptune") (...Company successfully completed as of,October 8, 20...debentures,for gross proceeds of $2,750,000., The...
Breaking Biology Technology:Six Sigma and Social Media: Tools for Reducing Costs, Improving Processes 2EMD Serono Named as a Top Employer by Science Magazine 2Environmental Tectonics Corporation Announces a Multiple Sale of Hyperbaric Monoplace Chambers to Comprehensive Healthcare Solutions 2Environmental Tectonics Corporation Announces a Multiple Sale of Hyperbaric Monoplace Chambers to Comprehensive Healthcare Solutions 3Environmental Tectonics Corporation Announces a Multiple Sale of Hyperbaric Monoplace Chambers to Comprehensive Healthcare Solutions 4Neptune Technologies successfully completes $2.75 million private placement with 10% management participation 2Neptune Technologies successfully completes $2.75 million private placement with 10% management participation 3Neptune Technologies successfully completes $2.75 million private placement with 10% management participation 4
... , , , , , , For total ..., , , , , , , ... , RNeasy Protect ... , , , ..., , RNeasy Protect...
... , , , , , , Optimized ... 293, and CHO cells , , Features a...cols for COS-7, NIH/3T3, HeLa, 293, and CHO cells ... No removal of transfection complexes requi...rum , High efficiency, Economi...
... , , , , , , For purifi...d or cosmid DNA , , Features and b... plasmid DNA , Yields of up to 10 mg pl...f plasmid DNA , Fast and simple procedu... * Actual yields depend on plasmid copy number, s...
... , , , , , , High-quali...s efficient , gene silencing in eukaryotic ... , mRNA. This effect, termed RNA interferen...g in functional genomics studies. Now, QIAGEN offe...is service that includes a range of modifications ...
Other Biology Technology:RNeasy Mini, Midi, and Maxi Kits 2RNeasy Mini, Midi, and Maxi Kits 3RNeasy Mini, Midi, and Maxi Kits 4PolyFect Transfection Reagent 2PolyFect Transfection Reagent 3PolyFect Transfection Reagent 4EndoFree Plasmid Kits 2EndoFree Plasmid Kits 3EndoFree Plasmid Kits 4Custom and library siRNA for efficient gene silencing 2Custom and library siRNA for efficient gene silencing 3Custom and library siRNA for efficient gene silencing 4
(Date:10/10/2008)...asterosteus aculeatus , is one of the most thoroug...particularly useful model for understanding variat...hology caused by different ecological situations i...r and genetic to developmental and morphological, ...as proven far more complex than even imagined. , ...
(Date:10/10/2008)... German . , DNA, the molecule that acts as the...fe, is highly resistant against alteration by ultr... its photostability presents some puzzling problem...r chemical bases that make up the DNA molecule. Re...wing that DNA strands differ in their light sensit...
(Date:10/9/2008)...wswire-FirstCall/ -- Aware, Inc. (Nasdaq:,AWRE), a...etrics software,has scheduled a conference call t...third quarter of 2008 on Thursday, October 23, 200...and CFO Rick Moberg will host the,earnings confere...and can be accessed on the,Investor Relations page...
(Date:10/9/2008)...you have to worry about hungry starfish and even h... can change your body temperature 50 degrees Fahre...st variable habitats on Earth," said USC biologist... bathed in cool Pacific seawater and the other par...the first real-time molecular sampling of mussels ...
Breaking Biology News(10 mins):Fitness in a changing world 2Fitness in a changing world 3Can genetic information be controlled by light? 2Aware Announces Q3 2008 Earnings Conference Call 2Brainy genes, not brawn, key to success on mussel beach 2Brainy genes, not brawn, key to success on mussel beach 3HealthSouth To Acquire Rehabilitation Unit at Medical Center of Arlington 23367 1HealthSouth To Acquire Rehabilitation Unit at Medical Center of Arlington 23367 2HealthSouth To Acquire Rehabilitation Unit at Medical Center of Arlington 23367 3Can recycling be used to treat cancer 3F 23363 1Can recycling be used to treat cancer 3F 23363 2BBVA Foundation Awards for Biodiversity Conservation 3917 1BBVA Foundation Awards for Biodiversity Conservation 3917 2BBVA Foundation Awards for Biodiversity Conservation 3917 3BBVA Foundation Awards for Biodiversity Conservation 3917 4E prescribing of Controlled Substances Moves Real Time Prescription Drug Monitoring Toward Reality 23356 1E prescribing of Controlled Substances Moves Real Time Prescription Drug Monitoring Toward Reality 23356 2
...he fascinating interactions between flowers and th...ersity of plants. In order to entice pollinators s...cessfully pollinate their flowers, plants have evo...ch nectar is best known. , Thirty years ago, rese...ted by butterflies contain substantial amounts of ...
...lephants learn to imitate sounds that are not typi...r humans of vocal learning in a non-primate terres...ature, further supports the idea that vocal learni...relationships among animals that separate and reun...s, and bats. , Researchers from the Amboseli Trust...
...cientists at the University of Cincinnati (UC) Col...adly type of secondary stroke known as cerebral va...the brain, cerebral vasospasm usually occurs three...as hemorrhagic stroke. Sixty percent of patients w...nd 40 percent of them die from it. , Vasospasm, s...
...or all its promise, the prospect of using nanopart...ucts has raised concerns about possible harmful ef...e University of Michigan are addressing those conc...ticles damage cell membranes—enough to cause cell ...ented. , "If you,re inventing these sorts of mater...
Other Biology News:Elephants imitate sounds as a form of social communication 2Researchers discover molecule that causes secondary stroke 2Probing The Promise And Perils Of Nanoparticles 2Probing The Promise And Perils Of Nanoparticles 3
...ostics Cytomegalovirus (CMV) pp65 Antigenemia Immu...litative identification of lower matrix protein pp... Kit Components: Erythrocyte Lysis Buffer - (...buffered ammonium chloride. (NH4CL) Fixation Solu...
The CultureWell cell culture systems provide an integrated set-up for preparing cultured cells for staining and imaging. Each system uses medical-grade silicone gaskets preassembled with standard opt
nuclear cap binding protein subunit 1, 80kDa, mRNA
GOAT ANTI SLI
Biology Products: